LEL Lilly(Eli)

 
TIDMLEL 
 
Date: December 12, 2011 
 
For Release: Immediately 
 
Refer to: (317) 276-5795 - Mark E. Taylor 
 
             Katherine Baicker Elected to Lilly Board of Directors 
 
The Board of Directors of Eli Lilly and Company (NYSE:LLY) has elected 
Katherine Baicker, Ph.D. as a new member, effective December 12, 2011. Baicker, 
40, is Professor of Health Economics in the Department of Health Policy and 
Management at the Harvard School of Public Health. She is also a research 
associate at the National Bureau of Economic Research and an elected member of 
the Institute of Medicine. As a member of Lilly's board, Professor Baicker will 
serve on the public policy and compliance committee. She will serve under 
interim election and will stand for election by Lilly shareholders at the 
company's annual meeting in April, 2012. 
 
"I am very pleased to welcome Kate Baicker to the Lilly board. Her experience 
and expertise will surely benefit Lilly shareholders and the patients we 
serve," commented John Lechleiter, Ph.D., Lilly chairman, president and chief 
executive officer. "Kate is a leading researcher in the fields of health 
economics, public economics and labor economics. As a valued advisor to 
numerous healthcare-related commissions and committees, her expertise in 
healthcare policy and healthcare delivery is recognized by both academia and 
government. In a rapidly-changing healthcare landscape, Kate's insights will be 
invaluable as we work to sustain an environment that is conducive to medical 
innovation while still ensuring access to affordable, quality healthcare." 
 
Professor Baicker's research focuses primarily on the factors that drive the 
distribution, generosity, and effectiveness of public and private health 
insurance, with a particular focus on health insurance finance and the effect 
of reforms on the distribution and quality of care.  Her research has been 
published in journals such as Health Affairs, the Journal of Public Economics, 
and the Quarterly Journal of Economics, and has been featured in the New York 
Times, the Wall Street Journal, Business Week, and on National Public Radio. 
She is currently one of the leaders of a research program investigating the 
many effects of expanding health insurance coverage in the context of a 
randomized Medicaid expansion in Oregon. 
 
Prior to her current position at the Harvard School of Public Health, Professor 
Baicker served as a Senate-confirmed Member of the President's Council of 
Economic Advisers from 2005 - 2007, where she played a leading role in the 
development of health policy.  She currently serves on the Editorial Boards of 
Health Affairs, the Journal of Health Economics, and the Forum for Health 
Economics and Policy; as Vice Chair of the Board of Directors of AcademyHealth; 
on the Congressional Budget Office's Panel of Health Advisers; and as a 
Commissioner on the Medicare Payment Advisory Commission. 
 
About Lilly 
 
Lilly, a leading innovation-driven corporation, is developing a growing 
portfolio of pharmaceutical products by applying the latest research from its 
own worldwide laboratories and from collaborations with eminent scientific 
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - 
through medicines and information - for some of the world's most urgent medical 
needs. Additional information about Lilly is available at www.lilly.com. 
 
C-LLY 
 
 
 
Eli Lilly and Company 
 
Lilly Corporate Center 
 
Indianapolis, Indiana 46285 
 
U.S.A. 
 
www.lilly.com 
 
 
 
 
 
 
 
 
 
 
 
 
END 
 

Lilly(Eli) (LSE:LEL)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Lilly(Eli) (LSE:LEL)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025